T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Banc of California
BANC
$3.11B
| $2.33M | ﹤0.01% |
120,756
+5,268
| +5% | +$94.4K |
|
1677
Cinemark Holdings
CNK
$4.31B
| $2.32M | ﹤0.01% |
99,655
+2,511
| +3% | +$66K |
|
1678
Sonos
SONO
$1.97B
| $2.31M | ﹤0.01% |
131,224
+17,863
| +16% | +$311K |
|
1679
WaFd
WAFD
$2.81B
| $2.29M | ﹤0.01% |
71,497
+4,070
| +6% | +$126K |
|
1680
Kemper
KMPR
$1.62B
| $2.29M | ﹤0.01% |
56,456
-59,136
| -51% | -$2.53M |
|
1681
Strategic Education
STRA
$1.84B
| $2.29M | ﹤0.01% |
28,505
+1,534
| +6% | +$122K |
|
1682
United Natural Foods
UNFI
$2.92B
| $2.29M | ﹤0.01% |
67,843
+3,979
| +6% | +$148K |
|
1683
Robert Half
RHI
$4.41B
| $2.28M | ﹤0.01% |
83,924
-310,310
| -79% | -$8.86M |
|
1684
National Vision
EYE
$1.49B
| $2.27M | ﹤0.01% |
87,859
+3,652
| +4% | +$98.2K |
|
|
PPLI
1685
People Inc
PPLI
$3.01B
| $2.26M | ﹤0.01% |
57,862
+2,415
| +4% | +$84.6K |
|
1686
First Bancorp
FBNC
$2.75B
| $2.26M | ﹤0.01% |
44,509
+1,699
| +4% | +$86.1K |
|
1687
Extreme Networks
EXTR
$3.2B
| $2.26M | ﹤0.01% |
135,604
+4,193
| +3% | +$77K |
|
1688
Madison Square Garden
MSGE
$4.08B
| $2.26M | ﹤0.01% |
41,868
+2,824
| +7% | +$136K |
|
1689
Enviri
NVRI
$580M
| $2.26M | ﹤0.01% |
125,926
+5,086
| +4% | +$75.8K |
|
1690
Northwest Natural Holdings
NWN
$2.13B
| $2.25M | ﹤0.01% |
48,167
+1,806
| +4% | +$84.2K |
|
1691
Virtu Financial
VIRT
$5.13B
| $2.25M | ﹤0.01% |
67,575
+2,663
| +4% | +$91.1K |
|
1692
Annexon
ANNX
$862M
| $2.23M | ﹤0.01% |
445,074
-39,701
| -8% | -$152K |
|
1693
Hayward Holdings
HAYW
$3.22B
| $2.23M | ﹤0.01% |
144,076
+15,179
| +12% | +$240K |
|
1694
Highwoods Properties
HIW
$3.51B
| $2.23M | ﹤0.01% |
86,173
+4,784
| +6% | +$135K |
|
|
CSGS
1695
DELISTED
CSG Systems International
CSGS
| $2.22M | ﹤0.01% |
28,921
-83,857
| -74% | -$6.19M |
|
1696
BigBear.ai
BBAI
$1.58B
| $2.21M | ﹤0.01% |
410,123
+202,854
| +98% | +$1.33M |
|
1697
FB Financial Corp
FBK
$3.1B
| $2.2M | ﹤0.01% |
39,483
+6,628
| +20% | +$370K |
|
1698
Prelude Therapeutics
PRLD
$433M
| $2.19M | ﹤0.01% |
755,956
-120,382
| -14% | -$203K |
|
1699
SM Energy
SM
$8.03B
| $2.19M | ﹤0.01% |
117,244
+6,525
| +6% | +$132K |
|
1700
BOK Financial
BOKF
$8.87B
| $2.19M | ﹤0.01% |
18,461
+230
| +1% | +$25.8K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.